Propranolol vs metoprolol vs labetalol: A comparative study in essential hypertension M. M. KubikJ. H. Coote Originals Pages: 1 - 6
Comparison of changes in the characteristics of β-adrenoceptors and responsiveness of human circulating lymphocytes during and after chronic administration of pindolol and propranolol Y. GiudicelliD. LacasaA. Leneveu Originals Pages: 7 - 12
Effect of beta-blocking drugs on beta-cell function and insulin sensitivity in hypertensive non-diabetic patients K. TöttermanL. GroopF. Fyhrquist Originals Pages: 13 - 17
Haemodynamic evaluation of Ibopamine in severe congestive heart failure G. C. ReffoM. TurrinPaolo Ghirardi Originals Pages: 19 - 22
The metabolic effects of dopamine in man A. PernetV. A. HammondD. G. Johnston Originals Pages: 23 - 28
Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man C. BarbieriM. ParodiA. Dubini Originals Pages: 29 - 32
Increase in plasma free fatty acids and natriuresis by xanthines may reflect adenosine antagonism K. -E. AnderssonN. JohannessonC. G. A. Persson Originals Pages: 33 - 38
Should the acetylator phenotype be determined when prescribing hydralazine for hypertension? L. E. RamsayJ. H. SilasS. Freestone Originals Pages: 39 - 42
Inter- and intra-subject variation in the first-pass elimination of highly cleared drugs during chronic dosing M. EichelbaumA. Somogyi Originals Pages: 47 - 53
Disposition of clotiazepam: Influence of age, sex, oral contraceptives, cimetidine, isoniazid and ethanol H. R. OchsD. J. GreenblattH. Grehl Originals Pages: 55 - 59
The effect of alcoholic cirrhosis on the two kinetic components (high and low affinity) of the microsomal 0-deethylation of 7-ethoxycoumarin in human liver K. W. WoodhouseF. M. WilliamsM. D. Rawlins Originals Pages: 61 - 64
The effect of liver cirrhosis on the pharmacokinetics of phenprocoumon N. R. KitteringhamL. BüstgensE. E. Ohnhaus Originals Pages: 65 - 70
Effect of a reversible and selective MAO-A inhibitor (cimoxatone) on diurnal variation in plasma prolactin level in man M. Strolin BenedettiA. EschalierP. Dostert Originals Pages: 71 - 77
Pharmacokinetics and pharmacodynamics of transdermally administered clonidine D. ArndtsK. Arndts Originals Pages: 79 - 85
Pharmacokinetics of enprofylline in patients with impaired renal function after a single intravenous dose E. LunellO. BorgåR. Larsson Originals Pages: 87 - 93
Assessment of drug metabolism in hepatic disease: Comparison of plasma kinetics of oral cyclobarbital and the intravenous aminopyrine breath test U. Breyer-PfaffH. SeyfertE. -H. Egberts Originals Pages: 95 - 101
Entero-hepatic cycling of methotrexate estimated by use of the D-isomer as a reference marker J. HendelH. Brodthagen Originals Pages: 103 - 107
Pharmacokinetic evaluation of haemoperfusion in phenobarbital poisoning D. JacobsenE. Wiik-LarsenP. K. M. Lunde Originals Pages: 109 - 112
Pharmacokinetics of estramustine phosphate (Estracyt®) in prostatic cancer patients P. O. GunnarssonS. -B. AnderssonG. Plym-Forshell Originals Pages: 113 - 119
Nonlinear renal elimination kinetics of methotrexate due to saturation of renal tubular reabsorption J. HendelA. Nyfors Originals Pages: 121 - 124
Pharmacokinetics of nadolol in healthy subjects M. Schäfer-KortingN. BachE. Mutschler Short Communications Pages: 125 - 127
Dose-dependent pharmacokinetics of aprindine in healthy volunteers T. KobariT. ItohH. Hayakawa Short Communications Pages: 129 - 131
Steady state bioavailability of a new oral formulation of Hydergine® in geriatric patients F. SörgelE. AbischE. Lang Short Communications Pages: 133 - 135
Oral anticoagulation in patients surviving myocardial infarction. A new approach to old data E. A. LoeligerA. Leizorovicz Letter To The Editors Pages: 137 - 141
